(Updates to add link in 6th bullet to previous story on Philips.)
- The US Food and Drug Administration says
Philips Respironics is recalling some of its Trilogy EVO continuous ventilators due to a software-related possible power malfunction. - The product names are Trilogy EVO, Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal
- The products were distributed from March 20, 2019 to February 16, 2024
- Devices recalled in the US total 90,905
- Philips Respironics is providing a software update for its Trilogy Evo continuous ventilators to rectify the problem
- NOTE: From April 2024,
Philips Warns of Faulty Ventilators Amid Mounting Safety ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.